A carregar...
The Use of Chimeric Antigen Receptor T Cells in Patients With Non-Hodgkin Lymphoma
Resistance to conventional lines of therapy develops in approximately 20% of all patients with lymphoma. These patients have a dismal prognosis, with an expected median survival of 6.3 months. In recent years, T-cell immunotherapy has demonstrated a remarkable capacity to induce complete and durable...
Na minha lista:
| Publicado no: | Clin Adv Hematol Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6469642/ https://ncbi.nlm.nih.gov/pubmed/29851933 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|